معرفی
Sarah M. Kelting serves as Clinical Associate Professor and Cytopathology Fellowship Program Director in the Department of Pathology and Laboratory Medicine at the University of Kansas School of Medicine. Her dual clinical expertise bridges hematopathology and cytopathology with significant contributions to gynecologic pathology diagnostics.
Her educational journey includes:
- BA in Bachelor of Arts from University of Kansas, Lawrence
- MD from University of Kansas School of Medicine, Wichita
- Residency in Anatomic and Clinical Pathology at University of Virginia Health System
- Clinical Fellowship in Hematopathology at University of New Mexico Health Sciences Center
- Clinical Fellowship in Cytopathology at University of Kansas Medical Center
Dr. Kelting's research integrates morphologic analysis with molecular genetics to advance diagnostic precision in hematologic malignancies and cytology. Her work particularly addresses acute myeloid leukemia genomics, myelodysplastic syndrome classification, and adaptation of cervical screening protocols for transgender populations. She employs multimodal approaches combining immunophenotyping, flow cytometry, and immunohistochemistry to resolve diagnostic challenges in pancreatic and lymphoid malignancies.
Recent publications demonstrate consistent focus on hematopathology (67% of output) and cytopathology (33%), with emerging emphasis on molecular characterization of SRSF2-mutated AML (2023) and transgender-inclusive gynecologic cytology (2021). Key methodological trends include integration of next-generation sequencing data with traditional morphology and development of triaging algorithms for effusion specimens.
She maintains active board certifications:
- Anatomic & Clinical Pathology (American Board of Pathology)
- Cytopathology (American Board of Pathology)
- Hematopathology (American Board of Pathology)
As Cytopathology Fellowship Program Director, Dr. Kelting oversees comprehensive training in diagnostic cytology with emphasis on gynecologic, non-gynecologic, and molecular applications. Her leadership shapes curriculum development and competency assessment for future cytopathologists, though specific trainee details aren't documented. Research activities appear intrinsically linked to clinical service without mention of extramural grant funding.
Dr. Kelting operates within the integrated academic-clinical framework of KU Medical Center's pathology department, contributing to both the hematopathology division's diagnostic service and the cytopathology fellowship's educational mission through ongoing scholarly activity.
